Quarterly report [Sections 13 or 15(d)]

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)

v3.26.3
Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value $ 51,080 $ 59,511
Total liabilities at fair value 32,544 25,740
Other acquisitions    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity consideration in escrow and contingent consideration - Keystone and other acquisitions 3,302  
Level 1 | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market fund 25,559 23,111
Level 1 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 990
Level 2 | Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrant liabilities 0 540
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration asset related to sale of business 16,240 27,700
Indemnity holdback related to sale of business 9,281 8,700
Share-based payment liability-classified related to sale of business 16,830 15,138
Level 3 | Keystone Perfusion Services, LLC.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity consideration in escrow and contingent consideration - Keystone and other acquisitions 11,800 9,072
Level 3 | Other acquisitions    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity consideration in escrow and contingent consideration - Keystone and other acquisitions $ 3,914 $ 0